<DOC>
	<DOCNO>NCT01172132</DOCNO>
	<brief_summary>The purpose study determine : - Condition intensive care unit ( ICU ) admission patient haematological malignancy . - ICU hospital one year mortality . - Assessment post ICU burden health relate quality 90-d 1 year .</brief_summary>
	<brief_title>The Use Intensive Care Critically Ill Cancer Haematological Patients : `` TRIAL-OH ''</brief_title>
	<detailed_description>1 . To identify prognostic factor short medium term mortality , underline respective weight organ dysfunction characteristic underline malignancy 2 . Evaluate health relate quality life intensive care survivor ( SF36 ) 3 . Impact intensive care family burden ( HADS , IES ) . 4 . Assess clinician ' satisfaction ( intensivists , haematologist intensive care nurse ) relation medical decision-making . 5 . Establish relevance antifungal treatment .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<criteria>Hematological malignancy hospitalization ICU age &gt; = 18 year Patients already participate TRIALOH</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Leukemia</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Bone-Marrow Transplant</keyword>
	<keyword>Neutropenia</keyword>
	<keyword>Acute respiratory failure</keyword>
	<keyword>Mechanical ventilation</keyword>
	<keyword>Post ICU burden</keyword>
	<keyword>ICU triage</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Septic shock</keyword>
</DOC>